HPC-based Therapy

About Trailhead Biosystems

Trailhead Biosystems is a private, pre-revenue biotech company pioneering a platform approach to industrialize the production of induced pluripotent stem cell (iPSC)-derived human cells. Its core innovation is the High-Dimensional Design-of-Experiments (HD-DoE®) platform, which systematically optimizes differentiation protocols to generate consistent, high-quality cells for research and therapeutic use. The company is actively developing a portfolio of off-the-shelf research cells and pursuing therapeutic partnerships to advance cell therapies for neurological, metabolic, and hematological diseases. Trailhead operates as a platform and services company, offering custom differentiation and co-development partnerships to advance the regenerative medicine field.

Therapeutic Areas